+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Nektar Therapeutics - logo
Psoriasis (Immunology) - Drugs In Development, 2021 - Product Thumbnail Image

Psoriasis (Immunology) - Drugs In Development, 2021

  • Report
  • July 2021
  • 1178 Pages
From
Systemic Lupus Erythematosus (Immunology) - Drugs in Development, 2021 - Product Thumbnail Image

Systemic Lupus Erythematosus (Immunology) - Drugs in Development, 2021

  • Drug Pipelines
  • September 2021
  • 1013 Pages
From
Blood-Brain Barrier (BBB) Market (2nd Edition), 2020-2030: Focus on Non-Invasive Drug Delivery Technology Platforms and Therapeutics - Product Thumbnail Image

Blood-Brain Barrier (BBB) Market (2nd Edition), 2020-2030: Focus on Non-Invasive Drug Delivery Technology Platforms and Therapeutics

  • Report
  • March 2020
  • 357 Pages
From
Opioid Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 To 2029 - Product Thumbnail Image

Opioid Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 To 2029

  • Report
  • September 2021
  • 100 Pages
From
Opioid Induced Constipation Drugs Global Market Insights 2022, Analysis and Forecast to 2027, by Market Participants, Regions, Technology, Application - Product Thumbnail Image

Opioid Induced Constipation Drugs Global Market Insights 2022, Analysis and Forecast to 2027, by Market Participants, Regions, Technology, Application

  • Report
  • January 2022
  • 97 Pages
From
Opioid Induced Constipation (OIC) Drug Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Opioid Induced Constipation (OIC) Drug Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • August 2021
  • 113 Pages
From
Psoriasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Psoriasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • June 2022
  • 875 Pages
From
Medulloblastoma (Oncology) - Drugs in Development, 2021 - Product Thumbnail Image

Medulloblastoma (Oncology) - Drugs in Development, 2021

  • Report
  • December 2021
  • 556 Pages
From
Neuroblastoma (Oncology) - Drugs in Development, 2021 - Product Thumbnail Image

Neuroblastoma (Oncology) - Drugs in Development, 2021

  • Report
  • October 2021
  • 1265 Pages
From
Merkel Cell Carcinoma (Oncology) - Drugs in Development, 2021 - Product Thumbnail Image

Merkel Cell Carcinoma (Oncology) - Drugs in Development, 2021

  • Report
  • December 2021
  • 1010 Pages
From
Interleukin-2, a Tale of Two Halves: To Suppress or Augment Suppression, That is the Question - Product Thumbnail Image

Interleukin-2, a Tale of Two Halves: To Suppress or Augment Suppression, That is the Question

  • Report
  • May 2019
  • 17 Pages
From
Multiple Myeloma (Kahler Disease) (Oncology) - Drugs in Development, 2021 - Product Thumbnail Image

Multiple Myeloma (Kahler Disease) (Oncology) - Drugs in Development, 2021

  • Report
  • December 2021
  • 2980 Pages
From
Ulcerative Colitis (Gastrointestinal) - Drugs In Development, 2021 - Product Thumbnail Image

Ulcerative Colitis (Gastrointestinal) - Drugs In Development, 2021

  • Report
  • July 2021
  • 941 Pages
From
Merkel Cell Carcinoma Pipeline Analysis 2018 (Q1) - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments - Product Thumbnail Image

Merkel Cell Carcinoma Pipeline Analysis 2018 (Q1) - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

  • Report
  • April 2018
  • 85 Pages
From
Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030 - Product Thumbnail Image

Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030

  • Report
  • April 2020
  • 536 Pages
From
Interleukin-2 (IL-2) Receptor Agonist - Pipeline Insight, 2022 - Product Thumbnail Image

Interleukin-2 (IL-2) Receptor Agonist - Pipeline Insight, 2022

  • Clinical Trials
  • January 2022
  • 60 Pages
From
Dry Powder Inhaler Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update - Product Thumbnail Image

Dry Powder Inhaler Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

  • Report
  • May 2022
  • 156 Pages
From
Dry Powder Inhaler Devices - Medical Devices Pipeline Product Landscape, 2021 - Product Thumbnail Image

Dry Powder Inhaler Devices - Medical Devices Pipeline Product Landscape, 2021

  • Report
  • June 2021
From
Dry Powder Inhaler Devices - Medical Devices Pipeline Assessment, 2020 - Product Thumbnail Image

Dry Powder Inhaler Devices - Medical Devices Pipeline Assessment, 2020

  • Report
  • October 2020
  • 140 Pages
From
Psoriasis - Pipeline Review, H2 2020 - Product Thumbnail Image

Psoriasis - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 956 Pages
From
Loading Indicator